Janus Henderson Investors

Activity in this selectionFeb 28, 2026 · Feb 1, 2026

By stage

Series A1

Series B1

Series C+1

Biotech2

Space tech1

United States3

3 in this selection

Feb 18

Develops novel therapies to reduce the burden of neurodegenerative diseases

$175MSeries A

Role not disclosed

Feb 10

Developing a next-generation pertussis vaccine candidate BPZE1

$115MSeries B

Role not disclosed

Feb 2

Provides next-generation space and defense communications

$470MSeries C

Role not disclosed